Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSC) have been shown to improve wound healing and suppress inflammatory immune responses. Newer research also indicates that MSC exhibit antimicrobial activity, although the mechanisms underlying this activity have not been fully elucidated. Therefore, we conducted in vitro and in vivo studies to examine the ability of resting and activated MSC to kill bacteria, including multidrug resistant strains. We investigated direct bacterial killing mechanisms and the interaction of MSC with host innate immune responses to infection. In addition, the activity of MSC against chronic bacterial infections was investigated in a mouse biofilm infection model. We found that MSC exhibited high levels of spontaneous direct bactericidal activity in vitro. Moreover, soluble factors secreted by MSC inhibited Staphylococcus aureus biofilm formation in vitro and disrupted the growth of established biofilms. Secreted factors from MSC also elicited synergistic killing of drug-resistant bacteria when combined with several major classes of antibiotics. Other studies demonstrated interactions of activated MSC with host innate immune responses, including triggering of neutrophil extracellular trap formation and increased phagocytosis of bacteria. Finally, activated MSC administered systemically to mice with established S. aureus biofilm infections significantly reduced bacterial numbers at the wound site and improved wound healing when combined with antibiotic therapy. These results indicate that MSC generate multiple direct and indirect, immunologically mediated antimicrobial activities that combine to help eliminate chronic bacterial infections when the cells are administered therapeutically. Significance statement This study investigated the antimicrobial properties of human mesenchymal stem cells (MSC) and extends the results of previous studies by describing both the direct antimicrobial activity of MSC and the indirect antimicrobial effects mediated via interaction with host innate immune cells. This article describes in detail how MSC secreted factors augment the antimicrobial activity of nearly all classes of conventional antibiotics examined, including generating enhanced activity against drug-resistant strains of Staphylococcus aureus. This study with human MSC serves to bridge previous studies and suggests the utility of systemic delivery of activated MSC for treatment of chronic drug-resistant infection in human patients, in a scalable and clinically applicable manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed Central · Cited by 8,231
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156 · cited 2×
“Cocultures of bacteria and CM were incubated at 37 C in ambient air for 3 hours, then numbers of viable bacteria were determined by plating log10 serial dilutions on LB agar 4 quadrant plates (Thermo Fisher Scientific) and manual counting of colonies 24 hours later according to previously published protocol.(26)”
MethodMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Implant infections: adhesion, biofilm formation and immune evasion
Arciola, C. R., Campoccia, D., & Montanaro, L. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0019-y · Cited by 2,241 · cited 1×
“Methicillin-resistant Staphylococcus aureus (MRSA) in particular accounts for high mortality worldwide(2) and is responsible for many chronic implant infections.(3) The use of mesenchy-”
BackgroundAntimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927 · cited 1×
“MSC also produce antimicrobial peptides (AMPs), which are short peptides commonly found in neutrophils or epithelial cells.(17) AMPs kill bacteria directly by disrupting the integrity of the microbial membrane,(17) or by inducing the release of proinflammatory cytokines and in turn the recruitment of immune cells.”
BackgroundMesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318 · cited 1×
“Here, we also report that newly forming or already formed biofilms can be disrupted byMSC, highlighting the potential forMSC to be used as a treatment for chronic infections, including those often associated with biofilms.(40,41) We also found that MSC produced factors that F IGURE 7 Treatment of chronic biofilm infec…”
BackgroundThe role of bacterial biofilms in chronic infections
Bjarnsholt, T. (2013) · APMIS · doi:10.1111/apm.12099 · Cited by 1,080 · cited 1×
“Bacteria in biofilms live in an environment that favors bacterial persistence and evasion of host immune responses.(8) Within biofilms, bacteria elude killing from the immune system and antibiotics.”
BackgroundKrasnodembskaya, A., Song, Y., Fang, X., Gupta, N., Serikov, V., Lee, J.-W., & Matthay, M. A. (2010) · Stem Cells · doi:10.1002/stem.544 · Cited by 849 · cited 9×
“Each experiment was conducted using CM from three different donor MSC.”
BackgroundResultInfluentialNeutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-Orozco, A., Alvarado-Navarro, A., & Fafutis-Morris, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00081 · Cited by 686
Raffaghello, L., Bianchi, G., Bertolotto, M., Montecucco, F., Busca, A., Dallegri, F., Ottonello, L., & Pistoia, V. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0416 · Cited by 517
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481 · cited 1×
“It has also been reported previously that AMP such as LL-37 can synergize with conventional antibiotics for bacterial killing.(34,35) Therefore, we conducted studies to determine whether MSC CM contains factors that synergize with or exhibit additive bacteri-”
BackgroundVasandan, A. B., Jahnavi, S., Shashank, C., Prasad, P., Kumar, A., & Prasanna, S. J. (2016) · Scientific Reports · doi:10.1038/srep38308 · Cited by 406
Lee, J. W., Krasnodembskaya, A., McKenna, D. H., Song, Y., Abbott, J., & Matthay, M. A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-0990oc · Cited by 348 · cited 1×
“coli bioburden, and ameliorated acute lung injury including alveolar fluid clearance and inflammation.(25) However, few studies to date have investigated whether MSC can also be used in the treatment of chronic bacterial infections.”
BackgroundKrasnodembskaya, A., Samarani, G., Song, Y., Zhuo, H., Su, X., Lee, J.-W., Gupta, N., Petrini, M., & Matthay, M. A. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2011 · Cited by 333 · cited 1×
“aeruginosa in a mouse peritonitis and sepsis model.(23) MSC have also”
BackgroundMesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia
Gupta, N., Krasnodembskaya, A., Kapetanaki, M., Mouded, M., Tan, X., Serikov, V., & Matthay, M. A. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201176 · Cited by 331
Alcayaga-Miranda, F., Cuenca, J., & Khoury, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00339 · Cited by 296 · cited 13×
“Each experiment was conducted using CM from three different donor MSC.”
BackgroundMethodResultInfluentialNeutrophil Extracellular Traps: How to Generate and Visualize Them
Brinkmann, V., Laube, B., Abu Abed, U., Goosmann, C., & Zychlinsky, A. (2010) · Journal of Visualized Experiments · doi:10.3791/1724 · Cited by 291 · cited 1×
“Staining for neutrophil extracellular trap (NET) formation was performed according to a published protocol.(28,30) Cells were immunostained with antibodies for detection of histone H3 using Anti Histone H3 (RM188) Antibody (Caymen Chemical, Ann Arbor, Michigan) and neutrophil elastase AntiNeutrophil Elastase antibody…”
Slinker, B. K. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0655 · Cited by 277 · cited 1×
“05 interaction factors denoting synergistic interactions.(33) Synergy was defined as: an increased mean bacterial killing percentage of antibiotics with MSCCM compared with antibiotics alone or MSC alone.”
BackgroundGupta, A. K., Giaglis, S., Hasler, P., & Hahn, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097088 · Cited by 266 · cited 1×
“mediator of increased NET formation in response to MSC CM is IL8(45), which has been reported as a key inducer of NET.(46) Thus, our finding that pIC activation triggered increased secretion of IL-8 by”
BackgroundOptions and Limitations in Clinical Investigation of Bacterial Biofilms
Magana, M., Sereti, C., Ioannidis, A., Mitchell, C. A., Ball, A. R., Magiorkinis, E., Chatzipanagiotou, S., Hamblin, M. R., Hadjifrangiskou, M., & Tegos, G. P. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-16 · Cited by 242 · cited 1×
“Here, we also report that newly forming or already formed biofilms can be disrupted byMSC, highlighting the potential forMSC to be used as a treatment for chronic infections, including those often associated with biofilms.(40,41) We also found that MSC produced factors that F IGURE 7 Treatment of chronic biofilm infec…”
BackgroundCassatella, M. A., Mosna, F., Micheletti, A., Lisi, V., Tamassia, N., Cont, C., Calzetti, F., Pelletier, M., Pizzolo, G., & Krampera, M. (2011) · Stem Cells · doi:10.1002/stem.651 · Cited by 222 · cited 1×
“The same group also reported increased survival of neutrophils following exposure toMSCCM.(44) We also discovered that CM from activated MSC triggered a sig-”
BackgroundAdvances of Stem Cell Therapeutics in Cutaneous Wound Healing and Regeneration
Kanji, S., & Das, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/5217967 · Cited by 217
Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin
Scherr, T. D., Hanke, M. L., Huang, O., James, D. B. A., Horswill, A. R., Bayles, K. W., Fey, P. D., Torres, V. J., & Kielian, T. (2015) · mBio · doi:10.1128/mbio.01021-15 · Cited by 195 · cited 1×
“aureus biofilms can influence macrophage polarization and inhibit bacterial phagocytosis.(10) The compact three-dimensional struc-”
BackgroundDeciphering mechanisms of staphylococcal biofilm evasion of host immunity
Hanke, M. L., & Kielian, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00062 · Cited by 183 · cited 1×
“Within biofilms, bacteria elude killing from the immune system and antibiotics.(9) For example, S.”
BackgroundSung, D. K., Chang, Y. S., Sung, S. I., Yoo, H. S., Ahn, S. Y., & Park, W. S. (2016) · Cellular Microbiology · doi:10.1111/cmi.12522 · Cited by 173
Sutton, M. T., Fletcher, D., Ghosh, S. K., Weinberg, A., van Heeckeren, R., Kaur, S., Sadeghi, Z., Hijaz, A., Reese, J., Lazarus, H. M., et al. (2016) · Stem Cells International · doi:10.1155/2016/5303048 · Cited by 171
Activity of mesenchymal stem cells in therapies for chronic skin wound healing
Nuschke, A. (2014) · Organogenesis · doi:10.4161/org.27405 · Cited by 169
Alcayaga-Miranda, F., Cuenca, J., Martin, A., Contreras, L., Figueroa, F. E., & Khoury, M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0192-0 · Cited by 165
Harman, R. M., Yang, S. J., He, M. K., & de Walle, G. R. V. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0610-6 · Cited by 152 · cited 10×
“Each experiment was conducted using CM from three different donor MSC.”
BackgroundResultInfluentialFrançois, M., Romieu-Mourez, R., Stock-Martineau, S., Boivin, M.-N., Bramson, J. L., & Galipeau, J. (2009) · Blood · doi:10.1182/blood-2009-02-207795 · Cited by 146
Johnson, V., Webb, T., Norman, A., Coy, J., Kurihara, J., Regan, D., & Dow, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08311-4 · Cited by 144 · cited 10×
“We previously reported that activated mouse MSC were able to effectively control and eliminate biofilm infection in a mouse model when coadministered with a beta-lactam antibiotic (amoxi-clav).(4) However, it has not been determined previously whether human MSC exhibit similar activity against chronic S.”
BackgroundMethodResultInfluentialSelf-citationSioud, M., Mobergslien, A., Boudabous, A., & Fløisand, Y. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02378.x · Cited by 123 · cited 1×
“Staining for neutrophil extracellular trap (NET) formation was performed according to a published protocol.(28,30) Cells were immunostained with antibodies for detection of histone H3 using Anti Histone H3 (RM188) Antibody (Caymen Chemical, Ann Arbor, Michigan) and neutrophil elastase AntiNeutrophil Elastase antibody…”
MethodDynamic interactions of neutrophils and biofilms
Hirschfeld, J. (2014) · Journal of Oral Microbiology · doi:10.3402/jom.v6.26102 · Cited by 121 · cited 2×
“NETs is an important mechanism by which neutrophils can contain and eliminate bacterial infections.(11) Thus, activation of MSC appears to be an essential step in maximizing the interaction of MSC with host innate immune defenses to increase bacterial killing.”
BackgroundQu, W., Wang, Z., Hare, J. M., Bu, G., Mallea, J. M., Pascual, J. M., Caplan, A. I., Kurtzberg, J., Zubair, A. C., Kubrova, E., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0146 · Cited by 113
Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review
Najar, M., Krayem, M., Meuleman, N., Bron, D., & Lagneaux, L. (2017) · Immune Network · doi:10.4110/in.2017.17.2.89 · Cited by 111 · cited 1×
“Previous studies have shown that activating MSC with innate immune stimuli increases their immune modulatory properties.(27) In attempt to define their direct antimicrobial properties, we conducted studies to determine whether MSC activation through major innate immune pathways (Toll-like receptors, NOD-like receptors…”
BackgroundMesenchymal Stem Cells Augment the Anti-Bacterial Activity of Neutrophil Granulocytes
Brandau, S., Jakob, M., Bruderek, K., Bootz, F., Giebel, B., Radtke, S., Mauel, K., Jäger, M., Flohé, S. B., & Lang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106903 · Cited by 110 · cited 6×
“Each experiment was conducted using CM from three different donor MSC.”
ResultInfluentialJimenez-Puerta, G., Marchal, J., López-Ruiz, E., & Gálvez-Martín, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020445 · Cited by 106
Kadam, S., Shai, S., Shahane, A., & Kaushik, K. S. (2019) · Biomedicines · doi:10.3390/biomedicines7020035 · Cited by 91
Rabani, R., Volchuk, A., Jerkić, M., Ormesher, L., Garcés‐Ramírez, L., Canton, J., Masterson, C. H., Gagnon, S., Tatham, K. C., Marshall, J. C., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02021-2017 · Cited by 86 · cited 1×
“increased phagocytosis, mediated in part by NADPH oxidase activation.(14) Neutrophils exposed to MSC conditioned medium are resistant to apoptosis and demonstrate increased migration.”
BackgroundShurko, J. F., Galega, R., Li, C., & Lee, G. C. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0090-7 · Cited by 72 · cited 1×
“It has also been reported previously that AMP such as LL-37 can synergize with conventional antibiotics for bacterial killing.(34,35) Therefore, we conducted studies to determine whether MSC CM contains factors that synergize with or exhibit additive bacteri-”
BackgroundExploring the roles of MSCs in infections: focus on bacterial diseases
Marrazzo, P., Crupi, A. N., Alviano, F., Teodori, L., & Bonsi, L. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01752-6 · Cited by 65
Human mesenchymal stem cells protect neutrophils from serum-deprived cell death
Maqbool, M., Vidyadaran, S., George, E., & Ramasamy, R. (2011) · Cell Biology International · doi:10.1042/cbi20110070 · Cited by 55 · cited 2×
“influence the immunological properties of macrophages and neutrophils by secreting factors such as PGE2, 12 IL-6, IL-8, or IFN-β.(13) Following exposure to MSC-secreted factors, macrophages develop”
BackgroundYuan, Y., Lin, S., Guo, N., Zhao, C., Shen, S., Bu, X., & Ye, H. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.06.002 · Cited by 55 · cited 2×
“Although much of the direct antibacterial activity of MSC involving production of AMPs has been previously reported, little has been noted previously regarding the ability ofMSC to disrupt preexisting bacterial biofilms.(39) Here, we also report that newly forming or already formed biofilms can be disrupted byMSC, hig…”
BackgroundPerlee, D., de Vos, A. F., Scicluna, B. P., Mancheño‐Corvo, P., de la Rosa, O., Dalemans, W., Nürnberg, P., Lombardo, E., & van der Poll, T. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0260 · Cited by 51
Mesenchymal Stem Cell Soluble Mediators and Cystic Fibrosis
Sutton, M. T., Fletcher, D., Episalla, N. C., Auster, L., Folz, M. A., Roy, V., Heeckeren, R. V., Lennon, D. P., Caplan, A. I., & Bonfield, T. L. (2017) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000400 · Cited by 39 · cited 3×
“been shown to augment antibiotic treatment effects in murine cystic fibrosis,(24) in part by the secretion of LL-37.(16) Lastly, instillation of MSC into airways of explanted lungs have been shown to decrease E.”
BackgroundInfluentialA Preview of Selected Articles
Atkinson, S. P. (2017) · Stem Cells · doi:10.1002/stem.2745 · Cited by 9
(2017) · PubMed Central
Cited by
Biofilm therapy for chronic wounds
Liu, Y., Long, S., Wang, H., & Wang, Y. (2024) · International Wound Journal · doi:10.1111/iwj.14667 · Cited by 70
Mirshekar, M., Afkhami, H., Razavi, S., Masjedian Jazi, F., Darban-Sarokhalil, D., Ohadi, E., Nezhad, M. M., & Karimi, R. (2023) · Burns · doi:10.1016/j.burns.2023.01.005 · Cited by 39
Yadav, P., Vats, R., Bano, A., & Bhardwaj, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118588 · Cited by 36
“(vi) Bacterial clearance via the release of an antibacterial peptide [77].”
Teymouri, S., Yousefi, M. H., Heidari, S., Farokhi, S., Afkhami, H., & Kashfi, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-024-10163-x · Cited by 11
“They do not disturb the intestinal microbiota, lower cost, free of side effects, anti-biofilms, specific for bacteria, and do not affect eukaryotes [ 131] It can act as a synergy with antibiotics or even replace antibiotics [ 132] The possibility of non-self transplantation, the ability to produce…”
Metadata
- Authors
- Chow, L., Johnson, V., Impastato, R., Coy, J., Strumpf, A., & Dow, S.
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-08
- Volume
- 9
- Issue
- 2
- Pages
- 235-249
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- OpenAlex
- W2985019389
- Cited by
- 161
- References
- 51
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.